D. Lokanatha

1.2k total citations
71 papers, 806 citations indexed

About

D. Lokanatha is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D. Lokanatha has authored 71 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 23 papers in Pathology and Forensic Medicine and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D. Lokanatha's work include Lymphoma Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Breast Cancer Treatment Studies (10 papers). D. Lokanatha is often cited by papers focused on Lymphoma Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Breast Cancer Treatment Studies (10 papers). D. Lokanatha collaborates with scholars based in India, Spain and United Kingdom. D. Lokanatha's co-authors include KC Lakshmaiah, Linu Abraham Jacob, M. Babu, Govind Babu, L K Rajeev, Gita Bhat, P.P. Bapsy, Nathalie A. Lokker, William J. Gradishar and Shailesh Bondarde and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Cancer.

In The Last Decade

D. Lokanatha

62 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Lokanatha India 14 401 267 196 109 96 71 806
Seong Hyun Jeong South Korea 17 362 0.9× 216 0.8× 204 1.0× 226 2.1× 89 0.9× 67 761
Thomas J. Semrad United States 15 395 1.0× 257 1.0× 237 1.2× 99 0.9× 162 1.7× 51 890
Sandra J. Casak United States 18 455 1.1× 171 0.6× 215 1.1× 148 1.4× 107 1.1× 32 1.0k
Elona Juozaitytė Lithuania 17 397 1.0× 169 0.6× 143 0.7× 54 0.5× 112 1.2× 86 842
Jean Pierre Delord France 13 514 1.3× 233 0.9× 185 0.9× 60 0.6× 57 0.6× 20 792
Yabing Cao China 15 350 0.9× 191 0.7× 135 0.7× 87 0.8× 132 1.4× 52 811
Leonard Christopher Schmeel Germany 16 237 0.6× 130 0.5× 120 0.6× 50 0.5× 87 0.9× 67 816
KC Lakshmaiah India 13 324 0.8× 78 0.3× 184 0.9× 117 1.1× 61 0.6× 74 563
Tarek Assi Lebanon 17 400 1.0× 170 0.6× 334 1.7× 91 0.8× 125 1.3× 85 903
Claudio Dazzi Italy 17 556 1.4× 220 0.8× 494 2.5× 63 0.6× 211 2.2× 57 982

Countries citing papers authored by D. Lokanatha

Since Specialization
Citations

This map shows the geographic impact of D. Lokanatha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Lokanatha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Lokanatha more than expected).

Fields of papers citing papers by D. Lokanatha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Lokanatha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Lokanatha. The network helps show where D. Lokanatha may publish in the future.

Co-authorship network of co-authors of D. Lokanatha

This figure shows the co-authorship network connecting the top 25 collaborators of D. Lokanatha. A scholar is included among the top collaborators of D. Lokanatha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Lokanatha. D. Lokanatha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lokanatha, D., et al.. (2020). Primary mucinous carcinomas of the lung: Clinical characteristics and treatment outcomes. Lung India. 37(6). 491–491. 5 indexed citations
3.
Lokanatha, D., et al.. (2019). HIV/AIDS-related lymphoma: perspective from a regional cancer center in India. Blood Research. 54(3). 181–188. 10 indexed citations
4.
Babu, M., et al.. (2018). Treatment experience of thymoma and thymic carcinoma in tertiary cancer institute in India. Annals of Oncology. 29. ix149–ix149.
5.
Babu, Govind, et al.. (2018). Extranodal NK/T cell lymphoma- nasal type: Experience from an Indian regional cancer centre. Annals of Oncology. 29. ix89–ix90.
6.
Lakshmaiah, KC, et al.. (2018). Primary cutaneous B-cell lymphoma: A single-center 5-year experience. Indian Journal of Cancer. 55(2). 134–134. 3 indexed citations
7.
Jacob, Linu Abraham, KC Lakshmaiah, Govind Babu, et al.. (2018). Repeat biopsy a must in recurrent breast cancer: A study from tertiary cancer centre in India. Annals of Oncology. 29. ix16–ix17.
8.
Babu, Govind, D. Lokanatha, Linu Abraham Jacob, et al.. (2018). A prospective phase III randomized study to evaluate the efficacy of olanzapine for prevention of nausea and vomiting in patients receiving highly emetogenic chemotherapy (HEC). Annals of Oncology. 29. ix129–ix129. 1 indexed citations
9.
Lakshmaiah, KC, et al.. (2018). Induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma in adults: Results from a nonendemic region. Indian Journal of Cancer. 55(3). 257–257. 5 indexed citations
10.
Lakshmaiah, KC, et al.. (2017). Patterns and the Occurrence of KRAS Mutations in Metastatic Colorectal Cancers—a Study from Indian Regional Cancer Centre. Indian Journal of Surgical Oncology. 8(4). 511–513. 2 indexed citations
12.
Jacob, Linu Abraham, et al.. (2017). Genomic profiling of non-small cell lung cancer: A pilot study from South India. 2(2). 63–63. 2 indexed citations
13.
Lokanatha, D., et al.. (2016). Primary Parotid Lymphoma From A Regional Cancer Center in South India.. PubMed. 1(20). 25–9. 1 indexed citations
14.
Lakshmaiah, KC, et al.. (2016). Plasma cell leukemia: Single institution experience. Indian Journal of Cancer. 53(4). 619–619. 1 indexed citations
15.
16.
Baselga, José, Alexey Manikhas, Javier Cortés, et al.. (2014). Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer. Annals of Oncology. 25(3). 592–598. 75 indexed citations
17.
Lokanatha, D., et al.. (2013). Chronic Myeloid Leukemia with Variant Chromosomal Translocations: Results of Treatment with Imatinib Mesylate. SHILAP Revista de lepidopterología. 11(4). 2 indexed citations
18.
Lakshmaiah, KC, et al.. (2013). Periampullary Lymphoma Masquerading as Adenocarcinoma. Indian Journal of Surgical Oncology. 4(2). 155–157. 1 indexed citations
19.
Lokanatha, D., et al.. (2012). Systemic Therapy in Head and Neck Cancer: Changing Paradigm. Indian Journal of Surgical Oncology. 4(1). 19–26. 5 indexed citations
20.
Campo, J.M. del, Ricardo Hitt, P. Sebastian, et al.. (2011). Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck. British Journal of Cancer. 105(5). 618–627. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026